Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women

Breast Cancer Research and Treatment

Volumn 127, Issue 2, 2011, Pages 479-487

  Comen, E ^a   Balistreri, L ^a   Gonen M ^a   Dutra Clarke, A ^a   Fazio, M ^a   Vijai, J ^a   Stadler, Z ^a,b   Kauff, N ^a,b   Kirchhoff, T ^a   Hudis, C ^a,b   Offit, K ^a,b   Robson, M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Breast cancer risk; Risk prediction model; Single nucleotide polymorphism

Indexed keywords

BRCA1 PROTEIN; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; ETHNICITY; FEMALE; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; ALLELES; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; GERM-LINE MUTATION; HUMANS; MIDDLE AGED; MODELS, STATISTICAL; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; ROC CURVE; TIME FACTORS; YOUNG ADULT;

EID: 79958182015     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1215-2     Document Type: Article

References (33)

1. P Lichtenstein NV Holm PK Verkasalo A Iliadou J Kaprio M Koskenvuo E Pukkala A Skytthe K Hemminki 2000 Environmental and heritable factors in the causation of cancer analyses of cohorts of twins from Sweden, Denmark, and Finland N Engl J Med 343 2 78 85 10891514 10.1056/NEJM200007133430201 1:STN:280:DC%2BD3czjtFCiug%3D%3D (Pubitemid 30451850)
2. M Robson K Offit 2007 Clinical practice. Management of an inherited predisposition to breast cancer N Engl J Med 357 2 154 162 10.1056/NEJMcp071286 17625127 10.1056/NEJMcp071286 1:CAS:528:DC%2BD2sXnslSjsbk%3D (Pubitemid 47057733)
3. S Ahmed G Thomas M Ghoussaini CS Healey MK Humphreys R Platte J Morrison M Maranian KA Pooley R Luben D Eccles DG Evans O Fletcher N Johnson I dos Santos Silva J Peto MR Stratton N Rahman K Jacobs R Prentice GL Anderson A Rajkovic JD Curb RG Ziegler CD Berg SS Buys CA McCarty HS Feigelson EE Calle MJ Thun WR Diver S Bojesen BG Nordestgaard H Flyger T Dork P Schurmann P Hillemanns JH Karstens NV Bogdanova NN Antonenkova IV Zalutsky M Bermisheva S Fedorova E Khusnutdinova D Kang KY Yoo DY Noh SH Ahn P Devilee CJ van Asperen RA Tollenaar C Seynaeve M Garcia-Closas J Lissowska L Brinton B Peplonska H Nevanlinna T Heikkinen K Aittomaki C Blomqvist JL Hopper MC Southey L Smith AB Spurdle MK Schmidt A Broeks RR van Hien S Cornelissen RL Milne G Ribas A Gonzalez-Neira J Benitez RK Schmutzler B Burwinkel CR Bartram A Meindl H Brauch C Justenhoven U Hamann J Chang-Claude R Hein S Wang-Gohrke A Lindblom S Margolin A Mannermaa VM Kosma V Kataja JE Olson X Wang Z Fredericksen GG Giles G Severi L Baglietto DR English SE Hankinson DG Cox P Kraft LJ Vatten K Hveem M Kumle A Sigurdson M Doody P Bhatti BH Alexander MJ Hooning AM van den Ouweland RA Oldenburg M Schutte P Hall K Czene J Liu Y Li A Cox G Elliott I Brock MW Reed CY Shen JC Yu GC Hsu ST Chen H Anton-Culver A Ziogas IL Andrulis JA Knight J Beesley EL Goode F Couch G Chenevix-Trench RN Hoover BA Ponder DJ Hunter PD Pharoah AM Dunning SJ Chanock DF Easton 2009 Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 Nat Genet 41 5 585 590 10.1038/ng.354 19330027 10.1038/ng.354 1:CAS:528:DC%2BD1MXjsl2gu7c%3D
4. A Cox AM Dunning M Garcia-Closas S Balasubramanian MW Reed KA Pooley S Scollen C Baynes BA Ponder S Chanock J Lissowska L Brinton B Peplonska MC Southey JL Hopper MR McCredie GG Giles O Fletcher N Johnson I dos Santos Silva L Gibson SE Bojesen BG Nordestgaard CK Axelsson D Torres U Hamann C Justenhoven H Brauch J Chang-Claude S Kropp A Risch S Wang-Gohrke P Schurmann N Bogdanova T Dork R Fagerholm K Aaltonen C Blomqvist H Nevanlinna S Seal A Renwick MR Stratton N Rahman S Sangrajrang D Hughes F Odefrey P Brennan AB Spurdle G Chenevix-Trench J Beesley A Mannermaa J Hartikainen V Kataja VM Kosma FJ Couch JE Olson EL Goode A Broeks MK Schmidt FB Hogervorst LJ Van't Veer D Kang KY Yoo DY Noh SH Ahn S Wedren P Hall YL Low J Liu RL Milne G Ribas A Gonzalez-Neira J Benitez AJ Sigurdson DL Stredrick BH Alexander JP Struewing PD Pharoah DF Easton 2007 A common coding variant in CASP8 is associated with breast cancer risk Nat Genet 39 3 352 358 10.1038/ng1981 17293864 10.1038/ng1981 1:CAS:528: DC%2BD2sXitVOktrY%3D (Pubitemid 46328496)
5. DF Easton KA Pooley AM Dunning PD Pharoah D Thompson DG Ballinger JP Struewing J Morrison H Field R Luben N Wareham S Ahmed CS Healey R Bowman KB Meyer CA Haiman LK Kolonel BE Henderson L Le Marchand P Brennan S Sangrajrang V Gaborieau F Odefrey CY Shen PE Wu HC Wang D Eccles DG Evans J Peto O Fletcher N Johnson S Seal MR Stratton N Rahman G Chenevix-Trench SE Bojesen BG Nordestgaard CK Axelsson M Garcia-Closas L Brinton S Chanock J Lissowska B Peplonska H Nevanlinna R Fagerholm H Eerola D Kang KY Yoo DY Noh SH Ahn DJ Hunter SE Hankinson DG Cox P Hall S Wedren J Liu YL Low N Bogdanova P Schurmann T Dork RA Tollenaar CE Jacobi P Devilee JG Klijn AJ Sigurdson MM Doody BH Alexander J Zhang A Cox IW Brock G MacPherson MW Reed FJ Couch EL Goode JE Olson H Meijers-Heijboer A van den Ouweland A Uitterlinden F Rivadeneira RL Milne G Ribas A Gonzalez-Neira J Benitez JL Hopper M McCredie M Southey GG Giles C Schroen C Justenhoven H Brauch U Hamann YD Ko AB Spurdle J Beesley X Chen A Mannermaa VM Kosma V Kataja J Hartikainen NE Day DR Cox BA Ponder 2007 Genome-wide association study identifies novel breast cancer susceptibility loci Nature 447 7148 1087 1093 10.1038/nature05887 17529967 10.1038/nature05887 1:CAS:528:DC%2BD2sXmvFKmurc%3D (Pubitemid 47014426)
6. O Fletcher N Johnson L Gibson B Coupland A Fraser A Leonard I dos Santos Silva A Ashworth R Houlston J Peto 2008 Association of genetic variants at 8q24 with breast cancer risk Cancer Epidemiol Biomarkers Prev 17 3 702 705 10.1158/1055-9965.EPI-07-2564 18349290 10.1158/1055-9965.EPI-07-2564 1:CAS:528:DC%2BD1cXjtlKhtrg%3D (Pubitemid 351469223)
7. B Gold T Kirchhoff S Stefanov J Lautenberger A Viale J Garber E Friedman S Narod AB Olshen P Gregersen K Kosarin A Olsh J Bergeron NA Ellis RJ Klein AG Clark L Norton M Dean J Boyd K Offit 2008 Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33 Proc Natl Acad Sci USA 105 11 4340 4345 10.1073/pnas.0800441105 18326623 10.1073/pnas.0800441105 1:CAS:528:DC%2BD1cXktF2rs70%3D (Pubitemid 351754382)
8. DJ Hunter P Kraft KB Jacobs DG Cox M Yeager SE Hankinson S Wacholder Z Wang R Welch A Hutchinson J Wang K Yu N Chatterjee N Orr WC Willett GA Colditz RG Ziegler CD Berg SS Buys CA McCarty HS Feigelson EE Calle MJ Thun RB Hayes M Tucker DS Gerhard JF Fraumeni Jr RN Hoover G Thomas SJ Chanock 2007 A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer Nat Genet 39 7 870 874 10.1038/ng2075 17529973 10.1038/ng2075 1:CAS:528:DC%2BD2sXmvFKlsLg%3D (Pubitemid 47014500)
9. T Kirchhoff ZQ Chen B Gold P Pal MM Gaudet K Kosarin DA Levine P Gregersen S Spencer M Harlan M Robson RJ Klein CA Hudis L Norton M Dean K Offit 2009 The 6q22.33 locus and breast cancer susceptibility Cancer Epidemiol Biomarkers Prev 18 9 2468 2475 10.1158/1055-9965.EPI-09-0151 19690183 10.1158/1055-9965.EPI-09-0151 1:CAS:528:DC%2BD1MXhtFWltLbL
10. RL Milne J Benitez H Nevanlinna T Heikkinen K Aittomaki C Blomqvist JI Arias MP Zamora B Burwinkel CR Bartram A Meindl RK Schmutzler A Cox I Brock G Elliott MW Reed MC Southey L Smith AB Spurdle JL Hopper FJ Couch JE Olson X Wang Z Fredericksen P Schurmann M Bremer P Hillemanns T Dork P Devilee CJ van Asperen RA Tollenaar C Seynaeve P Hall K Czene J Liu Y Li S Ahmed AM Dunning M Maranian PD Pharoah G Chenevix-Trench J Beesley NV Bogdanova NN Antonenkova IV Zalutsky H Anton-Culver A Ziogas H Brauch C Justenhoven YD Ko S Haas PA Fasching R Strick AB Ekici MW Beckmann GG Giles G Severi L Baglietto DR English O Fletcher N Johnson I dos Santos Silva J Peto C Turnbull S Hines A Renwick N Rahman BG Nordestgaard SE Bojesen H Flyger D Kang KY Yoo DY Noh A Mannermaa V Kataja VM Kosma M Garcia-Closas S Chanock J Lissowska LA Brinton J Chang-Claude S Wang-Gohrke CY Shen HC Wang JC Yu ST Chen M Bermisheva T Nikolaeva E Khusnutdinova MK Humphreys J Morrison R Platte DF Easton 2009 Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042 J Natl Cancer Inst 101 14 1012 1018 10.1093/jnci/djp167 19567422 10.1093/jnci/djp167 1:CAS:528:DC%2BD1MXptVelur0%3D
11. SN Stacey A Manolescu P Sulem T Rafnar J Gudmundsson SA Gudjonsson G Masson M Jakobsdottir S Thorlacius A Helgason KK Aben LJ Strobbe MT Albers-Akkers DW Swinkels BE Henderson LN Kolonel L Le Marchand E Millastre R Andres J Godino MD Garcia-Prats E Polo A Tres M Mouy J Saemundsdottir VM Backman L Gudmundsson K Kristjansson JT Bergthorsson J Kostic ML Frigge F Geller D Gudbjartsson H Sigurdsson T Jonsdottir J Hrafnkelsson J Johannsson T Sveinsson G Myrdal HN Grimsson T Jonsson S von Holst B Werelius S Margolin A Lindblom JI Mayordomo CA Haiman LA Kiemeney OT Johannsson JR Gulcher U Thorsteinsdottir A Kong K Stefansson 2007 Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer Nat Genet 39 7 865 869 10.1038/ng2064 17529974 10.1038/ng2064 1:CAS:528:DC%2BD2sXmvFKlsL8%3D (Pubitemid 47014497)
12. SN Stacey A Manolescu P Sulem S Thorlacius SA Gudjonsson GF Jonsson M Jakobsdottir JT Bergthorsson J Gudmundsson KK Aben LJ Strobbe DW Swinkels KC van Engelenburg BE Henderson LN Kolonel L Le Marchand E Millastre R Andres B Saez J Lambea J Godino E Polo A Tres S Picelli J Rantala S Margolin T Jonsson H Sigurdsson T Jonsdottir J Hrafnkelsson J Johannsson T Sveinsson G Myrdal HN Grimsson SG Sveinsdottir K Alexiusdottir J Saemundsdottir A Sigurdsson J Kostic L Gudmundsson K Kristjansson G Masson JD Fackenthal C Adebamowo T Ogundiran OI Olopade CA Haiman A Lindblom JI Mayordomo LA Kiemeney JR Gulcher T Rafnar U Thorsteinsdottir OT Johannsson A Kong K Stefansson 2008 Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer Nat Genet 40 6 703 706 10.1038/ng.131 18438407 10.1038/ng.131 1:CAS:528:DC%2BD1cXmsVejsL8%3D (Pubitemid 351748861)
13. G Thomas KB Jacobs P Kraft M Yeager S Wacholder DG Cox SE Hankinson A Hutchinson Z Wang K Yu N Chatterjee M Garcia-Closas J Gonzalez-Bosquet L Prokunina-Olsson N Orr WC Willett GA Colditz RG Ziegler CD Berg SS Buys CA McCarty HS Feigelson EE Calle MJ Thun R Diver R Prentice R Jackson C Kooperberg R Chlebowski J Lissowska B Peplonska LA Brinton A Sigurdson M Doody P Bhatti BH Alexander J Buring IM Lee LJ Vatten K Hveem M Kumle RB Hayes M Tucker DS Gerhard JF Fraumeni Jr RN Hoover SJ Chanock DJ Hunter 2009 A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1) Nat Genet 41 5 579 584 10.1038/ng.353 19330030 10.1038/ng.353 1:CAS:528:DC%2BD1MXjsl2nsrs%3D
14. MH Gail 2008 Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk J Natl Cancer Inst 100 14 1037 1041 10.1093/jnci/djn180 18612136 10.1093/jnci/djn180 1:CAS:528:DC%2BD1cXoslGgtrk%3D (Pubitemid 352019794)
15. MH Gail 2009 Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model J Natl Cancer Inst 101 13 959 963 10.1093/jnci/djp130 19535781 10.1093/jnci/djp130 1:CAS:528:DC%2BD1MXosVWmu7o%3D
16. S Wacholder P Hartge R Prentice M Garcia-Closas HS Feigelson WR Diver MJ Thun DG Cox SE Hankinson P Kraft B Rosner CD Berg LA Brinton J Lissowska ME Sherman R Chlebowski C Kooperberg RD Jackson DW Buckman P Hui R Pfeiffer KB Jacobs GD Thomas RN Hoover MH Gail SJ Chanock DJ Hunter 2010 Performance of common genetic variants in breast-cancer risk models N Engl J Med 362 11 986 993 10.1056/NEJMoa0907727 20237344 10.1056/NEJMoa0907727 1:CAS:528: DC%2BC3cXjs1Kit7g%3D
17. Gabriel S, Ziaugra L, Tabbaa D (2009) SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet Chapter 2:Unit 2.12. doi: 10.1002/0471142905.hg0212s60
18. S Purcell B Neale K Todd-Brown L Thomas MA Ferreira D Bender J Maller P Sklar PI de Bakker MJ Daly PC Sham 2007 PLINK: a tool set for whole-genome association and population-based linkage analyses Am J Hum Genet 81 3 559 575 10.1086/519795 17701901 10.1086/519795 1:CAS:528:DC%2BD2sXhtVSqurrL (Pubitemid 47330214)
19. E Amir DG Evans A Shenton F Lalloo A Moran C Boggis M Wilson A Howell 2003 Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme J Med Genet 40 11 807 814 14627668 10.1136/jmg.40.11.807 1:STN:280:DC%2BD3srkvFartg%3D%3D (Pubitemid 37485490)
20. EB Claus N Risch WD Thompson 1994 Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction Cancer 73 3 643 651 8299086 10.1002/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5 1:STN:280:DyaK2c7jtVagug%3D%3D (Pubitemid 24046606)
21. JP Costantino MH Gail D Pee S Anderson CK Redmond J Benichou HS Wieand 1999 Validation studies for models projecting the risk of invasive and total breast cancer incidence J Natl Cancer Inst 91 18 1541 1548 10491430 10.1093/jnci/91.18.1541 1:STN:280:DyaK1Mvitlyguw%3D%3D (Pubitemid 29457958)
22. D Ford DF Easton DT Bishop SA Narod DE Goldgar 1994 Risks of cancer in BRCA1-mutation carriers. Breast cancer linkage consortium Lancet 343 8899 692 695 7907678 10.1016/S0140-6736(94)91578-4 1:STN:280:DyaK2c7otVKitQ%3D%3D (Pubitemid 24087847)
23. MH Gail LA Brinton DP Byar DK Corle SB Green C Schairer JJ Mulvihill 1989 Projecting individualized probabilities of developing breast cancer for white females who are being examined annually J Natl Cancer Inst 81 24 1879 1886 2593165 10.1093/jnci/81.24.1879 1:STN:280:DyaK3c%2FnvF2kuw%3D%3D (Pubitemid 20026073)
24. J Tyrer SW Duffy J Cuzick 2004 A breast cancer prediction model incorporating familial and personal risk factors Stat Med 23 7 1111 1130 10.1002/sim.1668 15057881 10.1002/sim.1668 (Pubitemid 38477070)
25. D Euhus 2004 Risk modeling in breast cancer Breast J 10 Suppl 1 S10 S12 14984482 10.1111/j.1524-4741.2004.101S4.x
26. DM Euhus KC Smith L Robinson A Stucky OI Olopade S Cummings JE Garber A Chittenden GB Mills P Rieger L Esserman B Crawford KS Hughes CA Roche PA Ganz J Seldon CJ Fabian J Klemp G Tomlinson 2002 Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO J Natl Cancer Inst 94 11 844 851 12048272 1:CAS:528:DC%2BD38Xlt1Sqs70%3D (Pubitemid 34705056)
27. P Kraft S Wacholder MC Cornelis FB Hu RB Hayes G Thomas R Hoover DJ Hunter S Chanock 2009 Beyond odds ratios-communicating disease risk based on genetic profiles Nat Rev Genet 10 4 264 269 10.1038/nrg2516 19238176 10.1038/nrg2516 1:CAS:528:DC%2BD1MXjt1Cku70%3D
28. MJ Pencina RB D'Agostino Sr RB D'Agostino Jr RS Vasan 2008 Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2 157 172 10.1002/sim.2929 17569110 10.1002/sim.2929 (discussion 207-212) (Pubitemid 351193639)
29. EW Steyerberg AJ Vickers NR Cook T Gerds M Gonen N Obuchowski MJ Pencina MW Kattan 2010 Assessing the performance of prediction models: a framework for traditional and novel measures Epidemiology 21 1 128 138 10.1097/EDE. 0b013e3181c30fb200001648-201001000-00022 20010215 10.1097/EDE.0b013e3181c30fb2
30. B Fisher JP Costantino DL Wickerham CK Redmond M Kavanah WM Cronin V Vogel A Robidoux N Dimitrov J Atkins M Daly S Wieand E Tan-Chiu L Ford N Wolmark 1998 Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study J Natl Cancer Inst 90 18 1371 1388 9747868 10.1093/jnci/90.18.1371 1:CAS:528:DyaK1cXmtlelurs%3D (Pubitemid 28439961)
31. VG Vogel JP Costantino DL Wickerham WM Cronin RS Cecchini JN Atkins TB Bevers L Fehrenbacher ER Pajon Jr JL Wade 3rd A Robidoux RG Margolese J James SM Lippman CD Runowicz PA Ganz SE Reis W McCaskill-Stevens LG Ford VC Jordan N Wolmark 2006 Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial JAMA 295 23 2727 2741 10.1001/jama.295.23. joc60074 16754727 10.1001/jama.295.23.joc60074 1:CAS:528:DC%2BD28XmtFOltLc%3D
32. D Saslow C Boetes W Burke S Harms MO Leach CD Lehman E Morris E Pisano M Schnall S Sener RA Smith E Warner M Yaffe KS Andrews CA Russell 2007 American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography CA Cancer J Clin 57 2 75 89 17392385 10.3322/canjclin.57.2.75 (Pubitemid 46535708)
33. H Zhong RL Prentice 2010 Correcting "winner's curse" in odds ratios from genomewide association findings for major complex human diseases Genet Epidemiol 34 1 78 91 10.1002/gepi.20437 19639606